[
  {
    "ts": null,
    "headline": "J&J (JNJ) Faces $8M Verdict Over Talc Case; Stock Still Gains 4.66% YTD",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18, Dean Omar Branham Shirley, LLP, a Dallas, Texas-based law firm, announced an $8 million verdict against Johnson & Johnson in Suffolk County, Massachusetts. The verdict was awarded to Janice Paluzzi, an 84-year-old Massachusetts woman […]",
    "url": "https://finnhub.io/api/news?id=3c236856a0bd4eb8e2a159d5c2ce925f6711075a32831a75212d89fd7bd2629b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750800117,
      "headline": "J&J (JNJ) Faces $8M Verdict Over Talc Case; Stock Still Gains 4.66% YTD",
      "id": 135516664,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18, Dean Omar Branham Shirley, LLP, a Dallas, Texas-based law firm, announced an $8 million verdict against Johnson & Johnson in Suffolk County, Massachusetts. The verdict was awarded to Janice Paluzzi, an 84-year-old Massachusetts woman […]",
      "url": "https://finnhub.io/api/news?id=3c236856a0bd4eb8e2a159d5c2ce925f6711075a32831a75212d89fd7bd2629b"
    }
  },
  {
    "ts": null,
    "headline": "MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal",
    "summary": "Merck's Winrevair meets goal in a phase III study in newly diagnosed PAH patients, showing strong efficacy.",
    "url": "https://finnhub.io/api/news?id=ffef75392d5f3cc01f3cab272e4aac23f379d5a91e27ee6aae3a81202292688b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750782000,
      "headline": "MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal",
      "id": 135515153,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Merck's Winrevair meets goal in a phase III study in newly diagnosed PAH patients, showing strong efficacy.",
      "url": "https://finnhub.io/api/news?id=ffef75392d5f3cc01f3cab272e4aac23f379d5a91e27ee6aae3a81202292688b"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?",
    "summary": "PFE faces a decline in COVID revenues, LOE pressure and IRA impacts but rising EPS estimates offer a glimmer of resilience.",
    "url": "https://finnhub.io/api/news?id=5c4f7360a1b1e638f10f9ab708d3565e404a83552a33b49e9cbfe943a62a8e22",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750775100,
      "headline": "Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?",
      "id": 135506341,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "PFE faces a decline in COVID revenues, LOE pressure and IRA impacts but rising EPS estimates offer a glimmer of resilience.",
      "url": "https://finnhub.io/api/news?id=5c4f7360a1b1e638f10f9ab708d3565e404a83552a33b49e9cbfe943a62a8e22"
    }
  },
  {
    "ts": null,
    "headline": "5 Dividend Stocks Poised to Profit From the AI Efficiency Boom",
    "summary": "Boring dividend stocks are becoming the smartest way to profit from AI's efficiency revolution.  Microsoft (NASDAQ: MSFT) is using AI-powered code-completion tools to help developers write code 55% faster.  Johnson & Johnson (NYSE: JNJ) is leveraging AI to accelerate drug-discovery timelines.",
    "url": "https://finnhub.io/api/news?id=9208af17d327883e3e55f6757f31a0e35f7824bcd4ddc2a2f47e8634612b63e6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750766400,
      "headline": "5 Dividend Stocks Poised to Profit From the AI Efficiency Boom",
      "id": 135496896,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Boring dividend stocks are becoming the smartest way to profit from AI's efficiency revolution.  Microsoft (NASDAQ: MSFT) is using AI-powered code-completion tools to help developers write code 55% faster.  Johnson & Johnson (NYSE: JNJ) is leveraging AI to accelerate drug-discovery timelines.",
      "url": "https://finnhub.io/api/news?id=9208af17d327883e3e55f6757f31a0e35f7824bcd4ddc2a2f47e8634612b63e6"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson: Undervalued Dividend King With 65% Upside Potential",
    "summary": "Johnson & Johnson offers stability with 62 years of dividend growth and a 3.44% yield. Click for why JNJ is undervalued and poised for potential 65% upside.",
    "url": "https://finnhub.io/api/news?id=ad8e98110d6e9178ba9b500d6bbbfb8869489d5d11417dbc8c3145bd3187c0d3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750765775,
      "headline": "Johnson & Johnson: Undervalued Dividend King With 65% Upside Potential",
      "id": 135506352,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1916635270/image_1916635270.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Johnson & Johnson offers stability with 62 years of dividend growth and a 3.44% yield. Click for why JNJ is undervalued and poised for potential 65% upside.",
      "url": "https://finnhub.io/api/news?id=ad8e98110d6e9178ba9b500d6bbbfb8869489d5d11417dbc8c3145bd3187c0d3"
    }
  },
  {
    "ts": null,
    "headline": "ZEISS Vision Care US Names Healthcare Industry Veteran Gary Rosenblum as President and Chief Executive Officer",
    "summary": "HEBRON, Ky. - ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments, announced today that Gary Rosenblum has been named President and Chief...",
    "url": "https://finnhub.io/api/news?id=35c5ce3d4cb3e15da9eb64c7862484ac5aaf9b62b1e7f2931978868b77d7652f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750764493,
      "headline": "ZEISS Vision Care US Names Healthcare Industry Veteran Gary Rosenblum as President and Chief Executive Officer",
      "id": 135504050,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "HEBRON, Ky. - ZEISS Vision Care, one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments, announced today that Gary Rosenblum has been named President and Chief...",
      "url": "https://finnhub.io/api/news?id=35c5ce3d4cb3e15da9eb64c7862484ac5aaf9b62b1e7f2931978868b77d7652f"
    }
  },
  {
    "ts": null,
    "headline": "How To Build A $1,000,000 Dividend Portfolio That Could Yield 11%+ In 15 Years",
    "summary": "How To Build A $1,000,000 Dividend Portfolio That Could Yield 11%+ In 15 Years",
    "url": "https://finnhub.io/api/news?id=a195d6cf6f63ff3a582ba0781f7f880d2d995b0baa099181bc58ff07b3fec92f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750762800,
      "headline": "How To Build A $1,000,000 Dividend Portfolio That Could Yield 11%+ In 15 Years",
      "id": 135502108,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=a195d6cf6f63ff3a582ba0781f7f880d2d995b0baa099181bc58ff07b3fec92f"
    }
  },
  {
    "ts": null,
    "headline": "J&J introduces disposable contact lens for astigmatism and presbyopia",
    "summary": "The product claims to offer stable and clear vision across all distances and lighting conditions.",
    "url": "https://finnhub.io/api/news?id=5439cea2908b773f00feaf4ec3e56efaefa5182137729c0da7da18a88e2a60e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750756705,
      "headline": "J&J introduces disposable contact lens for astigmatism and presbyopia",
      "id": 135506343,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The product claims to offer stable and clear vision across all distances and lighting conditions.",
      "url": "https://finnhub.io/api/news?id=5439cea2908b773f00feaf4ec3e56efaefa5182137729c0da7da18a88e2a60e5"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Kings: June 2025",
    "summary": "Best Dividend Kings: June 2025",
    "url": "https://finnhub.io/api/news?id=e7f9e85a4222e3c9e945686a217e8d03a0107fbdca3d48cf019c12ddf89df918",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750754940,
      "headline": "Best Dividend Kings: June 2025",
      "id": 135497215,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=e7f9e85a4222e3c9e945686a217e8d03a0107fbdca3d48cf019c12ddf89df918"
    }
  },
  {
    "ts": null,
    "headline": "2 Dividend Aristocrats Bargains To Buy And 'Never Let Go'",
    "summary": "Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. Read about two such stocks that are undervalued vs. historical norms.",
    "url": "https://finnhub.io/api/news?id=bcae1d83887a65e6c9f9053eb28696afd7ae4c7b3be1ead657c7a557d5bd0369",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750752000,
      "headline": "2 Dividend Aristocrats Bargains To Buy And 'Never Let Go'",
      "id": 135496728,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1652791120/image_1652791120.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. Read about two such stocks that are undervalued vs. historical norms.",
      "url": "https://finnhub.io/api/news?id=bcae1d83887a65e6c9f9053eb28696afd7ae4c7b3be1ead657c7a557d5bd0369"
    }
  },
  {
    "ts": null,
    "headline": "Calamos Phineus Long/Short Fund Q1 2025 Commentary",
    "summary": "Calamos Phineus Long/Short Fund rose 0.93% in Q1 (Class I shares at NAV), compared with a price decline of -4.27% for the S&P 500 Index and loss of -2.15% for the MSCI World Index.",
    "url": "https://finnhub.io/api/news?id=891051a1dc91404d75c34be710173b376dcfbed9ef192ae0a1fbf0322cbe2d8f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750750260,
      "headline": "Calamos Phineus Long/Short Fund Q1 2025 Commentary",
      "id": 135496409,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1787650632/image_1787650632.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Calamos Phineus Long/Short Fund rose 0.93% in Q1 (Class I shares at NAV), compared with a price decline of -4.27% for the S&P 500 Index and loss of -2.15% for the MSCI World Index.",
      "url": "https://finnhub.io/api/news?id=891051a1dc91404d75c34be710173b376dcfbed9ef192ae0a1fbf0322cbe2d8f"
    }
  }
]